NeuroOne Medical Technologies Corporation
NMTCNASDAQHealthcare● Active
$3.48
+$0.02(+0.43%)
Market Cap$29954069
P/E Ratio—
52W High$6.96
52W Low$3.276
NeuroOne Medical Technologies Corporation (NMTC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NMTC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.25
Est. -$0.23 · -10.3%
Revenue
$0.00B
Est. $0.00B · -7.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
NMTC reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.58 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.23 | -$0.25 | -10.3% | $0.00B | $0.00B | -7.2% |
| ▲ Q1 FY2026 | Feb 17, 2026 | -$0.24 | -$0.18 | +25.0% | $0.00B | $0.00B | +8.9% |
| ▼ Q4 FY2025 | Dec 17, 2025 | -$0.04 | -$0.05 | -25.0% | $0.00B | $0.00B | +9.9% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.05 | -$0.03 | +40.0% | $0.00B | $0.00B | -6.6% |
| ▲ Q2 FY2025 | May 13, 2025 | -$0.09 | -$0.07 | +22.2% | $0.00B | $0.00B | +9.4% |
| ▲ Q1 FY2025 | Feb 12, 2025 | -$0.10 | $0.06 | +160.0% | $0.01B | $0.00B | +200.0% |
| ▼ Q4 FY2024 | Dec 17, 2024 | -$0.09 | -$0.11 | -22.2% | $0.00B | $0.00B | -84.9% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.58
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.25
EPS Est.
-$0.23
EPS Surpr.
-10.3%
Revenue
$0.00B
Q1 FY2026
Feb 17, 2026Beat
EPS Actual
-$0.18
EPS Est.
-$0.24
EPS Surpr.
+25.0%
Revenue
$0.00B
Q4 FY2025
Dec 17, 2025Miss
EPS Actual
-$0.05
EPS Est.
-$0.04
EPS Surpr.
-25.0%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.00B
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.09
EPS Surpr.
+22.2%
Revenue
$0.00B
Q1 FY2025
Feb 12, 2025Beat
EPS Actual
$0.06
EPS Est.
-$0.10
EPS Surpr.
+160.0%
Revenue
$0.01B
Q4 FY2024
Dec 17, 2024Miss
EPS Actual
-$0.11
EPS Est.
-$0.09
EPS Surpr.
-22.2%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.05 | $0.06 | $0.07 | 1 |
| Q2 FY2028 | $-0.61 | $-0.54 | $-0.49 | 1 |
| Q1 FY2028 | $-0.82 | $-0.72 | $-0.65 | 1 |
| Q4 FY2027 | $-0.34 | $-0.30 | $-0.27 | 1 |
| Q3 FY2027 | $-0.24 | $-0.21 | $-0.19 | 1 |
| Q2 FY2027 | $-0.45 | $-0.40 | $-0.36 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -10.3% | $4.33 | $4.39 | +1.39% |
| ▲ Q1 FY2026 | Feb 17, 2026 | +25.0% | $4.88 | $4.07 | -16.60% |
| ▼ Q4 FY2025 | Dec 17, 2025 | -25.0% | $4.24 | $4.01 | -5.42% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +40.0% | $5.16 | $4.98 | -3.49% |
| ▲ Q2 FY2025 | May 13, 2025 | +22.2% | $3.74 | $3.86 | +3.21% |
| ▲ Q1 FY2025 | Feb 12, 2025 | +160.0% | $6.54 | $6.72 | +2.75% |
| ▼ Q4 FY2024 | Dec 17, 2024 | -22.2% | $4.54 | $4.74 | +4.41% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -11.1% | $4.44 | $4.45 | +0.23% |
Q2 FY2026+1.39%
Report Date
May 12, 2026
EPS Beat/Miss
-10.3%
Price Before
$4.33
Price After
$4.39
Q1 FY2026-16.60%
Report Date
Feb 17, 2026
EPS Beat/Miss
+25.0%
Price Before
$4.88
Price After
$4.07
Q4 FY2025-5.42%
Report Date
Dec 17, 2025
EPS Beat/Miss
-25.0%
Price Before
$4.24
Price After
$4.01
Q3 FY2025-3.49%
Report Date
Aug 14, 2025
EPS Beat/Miss
+40.0%
Price Before
$5.16
Price After
$4.98
Q2 FY2025+3.21%
Report Date
May 13, 2025
EPS Beat/Miss
+22.2%
Price Before
$3.74
Price After
$3.86
Q1 FY2025+2.75%
Report Date
Feb 12, 2025
EPS Beat/Miss
+160.0%
Price Before
$6.54
Price After
$6.72
Q4 FY2024+4.41%
Report Date
Dec 17, 2024
EPS Beat/Miss
-22.2%
Price Before
$4.54
Price After
$4.74
Q3 FY2024+0.23%
Report Date
Aug 14, 2024
EPS Beat/Miss
-11.1%
Price Before
$4.44
Price After
$4.45
Avg Beat Reaction-3.53%
Avg Miss Reaction+0.15%
Beat Rate4 / 8 quarters
Largest Move-16.60% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NMTC ends December
NeuroOne Medical Technologies Corporation (NMTC) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.25 — missing the analyst consensus of $-0.23 by -10.3%. The next NMTC earnings date is expected around September 1, 2026.
Each quarter, investors track NMTC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NMTC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NMTC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NMTC earnings · 5 questionsNeuroOne Medical Technologies Corporation's next earnings report is expected around September 1, 2026. NMTC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NMTC historically reports after market close (AMC).
NMTC earnings datewhen is NMTC earningsNMTC next earnings datewhen does NMTC report earningsNMTC earnings calendar
▸ Source: FMP · NeuroOne Medical Technologies Corporation SEC filings · US GAAP · NeuroOne Medical Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026